Index
1 Market Overview
1.1 Product Overview and Scope of Softgel CDMO
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Softgel CDMO by Type
1.3.1 Overview: Global Softgel CDMO Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Softgel CDMO Consumption Value Market Share by Type in 2022
1.3.3 Pharmaceutical Softgel CDMO
1.3.4 Nutraceutical Softgel CDMO
1.3.5 Others
1.4 Global Softgel CDMO Market by Application
1.4.1 Overview: Global Softgel CDMO Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Pharmaceutical Company
1.4.3 Biotechnology Company
1.4.4 Others
1.5 Global Softgel CDMO Market Size & Forecast
1.6 Global Softgel CDMO Market Size and Forecast by Region
1.6.1 Global Softgel CDMO Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Softgel CDMO Market Size by Region, (2018-2029)
1.6.3 North America Softgel CDMO Market Size and Prospect (2018-2029)
1.6.4 Europe Softgel CDMO Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Softgel CDMO Market Size and Prospect (2018-2029)
1.6.6 South America Softgel CDMO Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Softgel CDMO Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Catalent
2.1.1 Catalent Details
2.1.2 Catalent Major Business
2.1.3 Catalent Softgel CDMO Product and Solutions
2.1.4 Catalent Softgel CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Catalent Recent Developments and Future Plans
2.2 Aenova
2.2.1 Aenova Details
2.2.2 Aenova Major Business
2.2.3 Aenova Softgel CDMO Product and Solutions
2.2.4 Aenova Softgel CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Aenova Recent Developments and Future Plans
2.3 Sirio Pharma
2.3.1 Sirio Pharma Details
2.3.2 Sirio Pharma Major Business
2.3.3 Sirio Pharma Softgel CDMO Product and Solutions
2.3.4 Sirio Pharma Softgel CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Sirio Pharma Recent Developments and Future Plans
2.4 Procaps
2.4.1 Procaps Details
2.4.2 Procaps Major Business
2.4.3 Procaps Softgel CDMO Product and Solutions
2.4.4 Procaps Softgel CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Procaps Recent Developments and Future Plans
2.5 Patheon
2.5.1 Patheon Details
2.5.2 Patheon Major Business
2.5.3 Patheon Softgel CDMO Product and Solutions
2.5.4 Patheon Softgel CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Patheon Recent Developments and Future Plans
2.6 NextPharma
2.6.1 NextPharma Details
2.6.2 NextPharma Major Business
2.6.3 NextPharma Softgel CDMO Product and Solutions
2.6.4 NextPharma Softgel CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 NextPharma Recent Developments and Future Plans
2.7 Lonza
2.7.1 Lonza Details
2.7.2 Lonza Major Business
2.7.3 Lonza Softgel CDMO Product and Solutions
2.7.4 Lonza Softgel CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Lonza Recent Developments and Future Plans
2.8 Samsung Biologics
2.8.1 Samsung Biologics Details
2.8.2 Samsung Biologics Major Business
2.8.3 Samsung Biologics Softgel CDMO Product and Solutions
2.8.4 Samsung Biologics Softgel CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Samsung Biologics Recent Developments and Future Plans
2.9 Fareva
2.9.1 Fareva Details
2.9.2 Fareva Major Business
2.9.3 Fareva Softgel CDMO Product and Solutions
2.9.4 Fareva Softgel CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Fareva Recent Developments and Future Plans
2.10 WuXi AppTech
2.10.1 WuXi AppTech Details
2.10.2 WuXi AppTech Major Business
2.10.3 WuXi AppTech Softgel CDMO Product and Solutions
2.10.4 WuXi AppTech Softgel CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 WuXi AppTech Recent Developments and Future Plans
2.11 WuXi Biologics
2.11.1 WuXi Biologics Details
2.11.2 WuXi Biologics Major Business
2.11.3 WuXi Biologics Softgel CDMO Product and Solutions
2.11.4 WuXi Biologics Softgel CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 WuXi Biologics Recent Developments and Future Plans
2.12 Siegfried
2.12.1 Siegfried Details
2.12.2 Siegfried Major Business
2.12.3 Siegfried Softgel CDMO Product and Solutions
2.12.4 Siegfried Softgel CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Siegfried Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Softgel CDMO Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Softgel CDMO by Company Revenue
3.2.2 Top 3 Softgel CDMO Players Market Share in 2022
3.2.3 Top 6 Softgel CDMO Players Market Share in 2022
3.3 Softgel CDMO Market: Overall Company Footprint Analysis
3.3.1 Softgel CDMO Market: Region Footprint
3.3.2 Softgel CDMO Market: Company Product Type Footprint
3.3.3 Softgel CDMO Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Softgel CDMO Consumption Value and Market Share by Type (2018-2023)
4.2 Global Softgel CDMO Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Softgel CDMO Consumption Value Market Share by Application (2018-2023)
5.2 Global Softgel CDMO Market Forecast by Application (2024-2029)
6 North America
6.1 North America Softgel CDMO Consumption Value by Type (2018-2029)
6.2 North America Softgel CDMO Consumption Value by Application (2018-2029)
6.3 North America Softgel CDMO Market Size by Country
6.3.1 North America Softgel CDMO Consumption Value by Country (2018-2029)
6.3.2 United States Softgel CDMO Market Size and Forecast (2018-2029)
6.3.3 Canada Softgel CDMO Market Size and Forecast (2018-2029)
6.3.4 Mexico Softgel CDMO Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Softgel CDMO Consumption Value by Type (2018-2029)
7.2 Europe Softgel CDMO Consumption Value by Application (2018-2029)
7.3 Europe Softgel CDMO Market Size by Country
7.3.1 Europe Softgel CDMO Consumption Value by Country (2018-2029)
7.3.2 Germany Softgel CDMO Market Size and Forecast (2018-2029)
7.3.3 France Softgel CDMO Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Softgel CDMO Market Size and Forecast (2018-2029)
7.3.5 Russia Softgel CDMO Market Size and Forecast (2018-2029)
7.3.6 Italy Softgel CDMO Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Softgel CDMO Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Softgel CDMO Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Softgel CDMO Market Size by Region
8.3.1 Asia-Pacific Softgel CDMO Consumption Value by Region (2018-2029)
8.3.2 China Softgel CDMO Market Size and Forecast (2018-2029)
8.3.3 Japan Softgel CDMO Market Size and Forecast (2018-2029)
8.3.4 South Korea Softgel CDMO Market Size and Forecast (2018-2029)
8.3.5 India Softgel CDMO Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Softgel CDMO Market Size and Forecast (2018-2029)
8.3.7 Australia Softgel CDMO Market Size and Forecast (2018-2029)
9 South America
9.1 South America Softgel CDMO Consumption Value by Type (2018-2029)
9.2 South America Softgel CDMO Consumption Value by Application (2018-2029)
9.3 South America Softgel CDMO Market Size by Country
9.3.1 South America Softgel CDMO Consumption Value by Country (2018-2029)
9.3.2 Brazil Softgel CDMO Market Size and Forecast (2018-2029)
9.3.3 Argentina Softgel CDMO Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Softgel CDMO Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Softgel CDMO Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Softgel CDMO Market Size by Country
10.3.1 Middle East & Africa Softgel CDMO Consumption Value by Country (2018-2029)
10.3.2 Turkey Softgel CDMO Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Softgel CDMO Market Size and Forecast (2018-2029)
10.3.4 UAE Softgel CDMO Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Softgel CDMO Market Drivers
11.2 Softgel CDMO Market Restraints
11.3 Softgel CDMO Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Softgel CDMO Industry Chain
12.2 Softgel CDMO Upstream Analysis
12.3 Softgel CDMO Midstream Analysis
12.4 Softgel CDMO Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer